Clinical Trial Update: Additional Benefit of Cilostazol to Dual Antiplatelet Therapy After Biolimus-eluting Stent Implantation [Phase 4]

View source ↗

Summary

Phase 4 trial update indicates that adding cilostazol to dual antiplatelet therapy after biolimus-eluting stent implantation may provide additional benefit in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• cilostazol (Pletal) (cilostazol)

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED